LTRN
Lantern Pharma Inc.
Company overview
- Market capitalization
- $13.93M
- Employees
- 16
- Latest publication
- 2026-09-29
About Lantern Pharma Inc.
Lantern Pharma Inc. focuses on the discovery and development of oncology drug in India. Its product pipeline comprises LP-300, which is in phase 2 clinical trial in combination therapy for never-smokers with non-small cell lung cancer adenocarcinoma; LP-184, which is in phase 1a clinical trial for the treatment of advanced or metastatic solid tumors, or unresectable or recurrent GBM, solid tumor, such as pancreatic, breast, bladder, and lung cancers, as well as glioblastoma and other central nervous system (CNS) cancers; and LP-284, which is in phase 1 clinical trial for the treatment of non-Hodgkin's lymphomas, including mantle cell lymphoma and double hit lymphoma. The company also develops STAR-001, which is in preclinical development for the treatment of glioblastoma, brain metastases, atypical teratoid rhabdoid tumors, and several rare pediatric CNS cancers. In addition, it provides ADC program, an antibody drug conjugate therapeutic approach for cancer treatment. The company has a strategic AI-driven collaboration with Oregon Therapeutics to optimize the development of its first-in-class protein disulfide isomerase inhibitor drug candidate XCE853 in novel and targeted cancer indications; a collaboration agreement with TTC Oncology, which focuses on the drug development of TTC-352 to treat patients with metastatic ER+ breast cancer; and a collaboration agreement with Actuate Therapeutics, Inc. that focuses on the development of compounds for use in the treatment of cancer and inflammatory diseases leading to fibrosis. The company was incorporated in 2013 and is headquartered in Dallas, Texas.
Financial statements
Income Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 0USD | 100,654USD | 100,654USD | 0USD | 0USD |
| Cost Of Revenue | 3,853USD | -4,102USD | 4,102USD | 4,501USD | 4,574USD | 51,224USD | 47,858USD | 46,266USD |
| Gross Profit | -3,853USD | 4,102USD | -4,102USD | -4,501USD | -4,574USD | -51,224USD | -47,858USD | -46,266USD |
| Research Development | 1,724,872USD | 2,744,818USD | 2,436,971USD | 3,068,379USD | 3,263,955USD | 4,269,521USD | 3,716,646USD | 3,888,737USD |
| Selling General Administrative | 1,680,375USD | 1,457,944USD | 1,912,829USD | 1,525,721USD | 1,452,277USD | 1,626,878USD | 1,409,830USD | 1,519,724USD |
| Total Operating Expenses | 3,401,394USD | 4,202,762USD | 4,349,800USD | 4,651,900USD | 4,774,032USD | 5,845,175USD | 5,179,576USD | 5,408,461USD |
| Operating Income | -3,405,247USD | -4,202,762USD | -4,349,800USD | -4,651,900USD | -4,774,032USD | -5,896,399USD | -5,179,576USD | -5,408,461USD |
| Interest Income | 42,160USD | 72,475USD | 100,921USD | 114,745USD | 149,790USD | 161,393USD | 191,352USD | 188,660USD |
| Net Interest Income | 42,160USD | 72,475USD | 100,921USD | 114,745USD | 149,790USD | 161,393USD | 191,352USD | 188,660USD |
| Income Before Tax | -3,329,171USD | -4,074,217USD | -4,177,423USD | -4,331,015USD | -4,536,783USD | -5,875,200USD | -4,505,697USD | -4,959,506USD |
| Net Income | -3,329,171USD | -4,074,217USD | -4,177,423USD | -4,331,015USD | -4,536,783USD | -5,875,200USD | -4,505,697USD | -4,959,506USD |
| Net Income From Continuing Ops | -3,329,171USD | -4,074,217USD | -4,177,423USD | -4,331,015USD | -4,536,783USD | -5,875,200USD | -4,505,697USD | -4,959,506USD |
| Ebit | -3,405,247USD | -4,202,762USD | -4,349,800USD | -4,651,900USD | -4,774,032USD | -5,875,196USD | -5,179,576USD | -5,408,461USD |
| Ebitda | -3,401,394USD | -4,198,659USD | -4,345,698USD | -4,647,399USD | -4,769,458USD | -5,823,972USD | -5,175,187USD | -5,404,203USD |
| Depreciation And Amortization | 3,853USD | 4,103USD | 4,102USD | 4,501USD | 4,574USD | 51,224USD | 4,389USD | 4,258USD |
| Reconciled Depreciation | 3,853USD | 4,103USD | 4,102USD | 4,501USD | 4,574USD | 4,574USD | 4,389USD | 4,258USD |
| Total Other Income Expense Net | 76,076USD | 128,545USD | 172,377USD | 320,885USD | 237,249USD | 21,199USD | 673,879USD | 448,955USD |
| Selling And Marketing Expenses | — | 115,600USD | — | 57,800USD | 57,800USD | — | 53,100USD | 46,266USD |
| Income Tax Expense | — | — | — | — | -3USD | — | — | 4USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Cost Of Revenue | 17,280USD | 190,493USD | 174,843USD | 154,681USD | 97,421USD | 3,388USD | 1,627USD | -2,544USD |
| Gross Profit | -17,280USD | -190,493USD | -174,843USD | -154,681USD | -97,421USD | -3,388USD | -1,627USD | 2,544USD |
| Research Development | 11,514,123USD | 16,125,690USD | 11,894,315USD | 8,602,954USD | 7,570,580USD | 2,243,225USD | 953,185USD | 572,095USD |
| Selling General Administrative | 6,464,371USD | 6,090,747USD | 5,983,255USD | 5,829,799USD | 5,020,928USD | 3,664,965USD | 1,475,000USD | 1,154,322USD |
| Total Operating Expenses | 17,978,494USD | 22,216,437USD | 17,702,727USD | 14,432,753USD | 12,591,508USD | 5,908,190USD | 2,428,185USD | 1,726,417USD |
| Operating Income | -17,978,494USD | -22,216,437USD | -17,877,570USD | -14,432,753USD | -12,591,508USD | -5,908,190USD | -2,428,185USD | -1,726,417USD |
| Interest Income | 437,931USD | 742,355USD | 572,683USD | 204,355USD | 67,929USD | 0USD | — | — |
| Net Interest Income | 437,931USD | 742,355USD | 572,683USD | 204,355USD | 67,929USD | 0USD | — | — |
| Income Before Tax | -17,119,438USD | -20,781,213USD | -15,961,534USD | -14,259,946USD | -12,363,029USD | -5,908,190USD | -2,428,185USD | -1,726,417USD |
| Net Income | -17,119,438USD | -20,781,213USD | -15,961,534USD | -14,259,946USD | -12,363,029USD | -5,908,190USD | -2,428,185USD | -1,726,417USD |
| Net Income From Continuing Ops | -17,119,438USD | -20,781,213USD | -15,156,718USD | -14,259,946USD | -12,363,029USD | -5,908,190USD | -2,428,185USD | -1,726,417USD |
| Ebit | -17,978,494USD | -22,216,437USD | -15,961,532USD | -14,432,753USD | -12,591,508USD | -5,908,190USD | -2,428,185USD | -1,726,417USD |
| Ebitda | -17,961,214USD | -22,199,155USD | -15,786,689USD | -14,422,672USD | -12,584,747USD | -5,904,802USD | -2,426,558USD | -1,728,961USD |
| Depreciation And Amortization | 17,280USD | 17,282USD | 174,843USD | 10,081USD | 6,761USD | 3,388USD | 1,627USD | -2,544USD |
| Reconciled Depreciation | 17,280USD | 17,282USD | 13,400USD | 10,081USD | 6,761USD | 3,388USD | 1,627USD | -2,544USD |
| Total Other Income Expense Net | 859,056USD | 1,435,224USD | 1,916,036USD | 172,807USD | 228,479USD | — | -5USD | — |
| Income Tax Expense | — | — | -3USD | -172,807USD | -67,929USD | -202,909USD | -5USD | 2,544USD |
| Interest Expense | — | — | — | 204,355USD | 221,718USD | 0USD | 0USD | 0USD |
| Net Income Applicable To Common Shares | — | — | — | -14,259,946USD | -12,363,029USD | -5,908,190USD | -2,428,185USD | -1,726,417USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 8,602,349USD | 7,223,067USD | 11,035,811,000USD | 13,626,810USD | 17,420,292USD | 21,096,335USD | 25,571,792USD | 30,293,264USD |
| Cash And Equivalents | 6,660,170USD | — | — | — | — | — | — | — |
| Cash And Short Term Investments | 7,361,255USD | 6,322,853USD | 10,119,224,000USD | 12,362,576USD | 15,901,774USD | 19,721,651USD | 24,013,063USD | 28,053,765USD |
| Short Term Investments | 701,085USD | 1,405,057USD | 5,696,386,000USD | 3,973,090USD | 9,840,366USD | 13,344,049USD | 16,501,984USD | 19,950,946USD |
| Total Current Assets | 8,458,919USD | 7,057,260USD | 10,803,172,000USD | 13,461,005USD | 17,200,790USD | 20,823,376USD | 25,247,629USD | 29,920,960USD |
| Other Current Assets | 1,097,664USD | 734,407USD | 683,948,000USD | 1,098,429USD | 1,299,016USD | 1,101,725USD | 1,234,566USD | 1,867,195USD |
| Other Non Current Assets | 26,090USD | — | — | — | — | — | — | — |
| Total Liabilities | 11,819,601USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 4,322,512USD | 3,777,366USD | 4,501,587,000USD | 4,039,971USD | 4,884,363USD | 4,286,434USD | 4,331,175USD | 3,601,090USD |
| Total Stockholder Equity | -3,217,252USD | 3,445,701USD | 6,534,224,000USD | 9,586,838USD | 12,522,405USD | 16,776,485USD | 21,187,774USD | 26,598,221USD |
| Total Equity Including Noncontrolling Interest | -3,217,252USD | — | — | — | — | — | — | — |
| Property Plant Equipment Net | 62,513USD | 84,890USD | 107,470,000USD | 129,066USD | 182,764USD | 236,221USD | 287,425USD | 335,566USD |
| Accounts Payable | 4,282,797USD | — | — | 3,946,018USD | 4,752,848USD | 4,124,919USD | 4,140,361USD | 3,403,799USD |
| Short Term Debt | 39,715USD | 59,076USD | 78,539,000USD | 93,954USD | 131,515USD | 161,515USD | 190,814USD | 197,291USD |
| Common Stock | 1,276USD | 1,125USD | 1,125,000USD | 1,104USD | 1,078USD | 1,078USD | 1,078USD | 1,078USD |
| Retained Earnings | -103,546,350USD | -96,474,226USD | -93,145,055,000USD | -89,070,838USD | -84,893,415USD | -80,562,400USD | -76,025,617USD | -70,150,417USD |
| Accumulated Other Comprehensive Income | -39,759USD | -35,637USD | 25,430,000USD | 40,333USD | 48,043USD | 131,734USD | 153,990USD | -25,264USD |
| Total Liab | — | 3,777,366USD | 4,501,587,000USD | 4,039,971USD | 4,897,887USD | 4,319,850USD | 4,384,018USD | 3,695,043USD |
| Other Current Liab | — | 3,718,290USD | 4,423,048,000USD | 3,946,018USD | -131,515USD | 4,124,919USD | 4,140,361USD | 3,403,799USD |
| Capital Stock | — | 1,125USD | 1,125USD | 1,104USD | 1,078USD | 1,078USD | 1,078USD | 1,078USD |
| Cash | — | 4,917,796USD | 4,422,838,000USD | 8,389,486USD | 6,061,408USD | 6,377,602USD | 7,511,079USD | 8,102,819USD |
| Net Debt | — | -4,858,720USD | -4,344,299,000USD | -8,295,532USD | -5,916,369USD | -6,182,671USD | -7,267,422USD | -7,811,575USD |
| Short Long Term Debt Total | — | 59,076USD | 78,539,000USD | 93,954USD | 145,039USD | 194,931USD | 243,657USD | 291,244USD |
| Property Plant Equipment Gross | — | 84,890USD | 107,470USD | 129,067USD | 182,764USD | 236,221USD | 287,425USD | 335,566USD |
| Common Stock Shares Outstanding | — | 11,253,030shares | 10,898,000shares | 10,833,393shares | 10,784,725shares | 10,784,725shares | 10,784,725shares | 10,763,351shares |
| Non Current Assets Total | — | 165,807USD | 232,639,000USD | 165,805USD | 219,502USD | 272,959USD | 324,163USD | 372,304USD |
| Non Current Liabilities Total | — | 0USD | 0USD | 0USD | 13,524USD | 33,416USD | 52,843USD | 93,953USD |
| Non Currrent Assets Other | — | 80,917USD | 125,169,000USD | 36,738USD | 36,738USD | 36,738USD | 36,738USD | 36,738USD |
| Net Working Capital | — | 3,279,894USD | 6,301,585USD | 9,421,033USD | 12,316,427USD | 16,536,942USD | 20,916,454USD | 26,319,870USD |
| Unclassified Equity | — | 99,953,314USD | 99,652,722,875USD | 98,615,135USD | 97,365,621USD | 97,204,995USD | 97,057,245USD | 96,771,746USD |
| Unclassified Current Liabilities | — | — | — | -3,946,019USD | — | -4,124,919USD | -4,140,361USD | -3,403,799USD |
| Other Assets | — | — | — | — | — | 1USD | — | — |
| Net Receivables | — | — | — | — | — | — | 97,000USD | — |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 11,035,811,000USD | 25,571,792USD | 43,647,616USD | 58,836,321USD | 73,950,477USD | 20,359,634USD | 1,432,576USD | 449,831USD |
| Other Current Assets | 683,948,000USD | 1,234,566USD | 1,178,653USD | 3,526,652USD | 1,809,953USD | 1,007,690USD | 788USD | — |
| Total Liab | 4,501,587,000USD | 4,384,018USD | 2,739,682USD | 2,798,297USD | 2,379,057USD | 660,839USD | 489,292USD | 651,629USD |
| Total Stockholder Equity | 6,534,224,000USD | 21,187,774USD | 40,907,934USD | 56,038,024USD | 71,571,420USD | 19,698,795USD | 943,284USD | -201,798USD |
| Other Current Liab | 4,423,048,000USD | 4,140,361USD | 1,563,000USD | 2,745,407USD | 1,340,942USD | 120,000USD | 11,000USD | 554,000USD |
| Common Stock | 1,125,000USD | 1,078USD | 1,072USD | 1,086USD | 1,109USD | 622USD | 11,369USD | 11,369USD |
| Capital Stock | 1,125USD | 1,078USD | 1,072USD | 1,086USD | 1,109USD | 622USD | 25,385USD | 18,800USD |
| Retained Earnings | -93,145,055,000USD | -76,025,617USD | -55,244,404USD | -39,282,870USD | -25,022,924USD | -12,659,895USD | -6,751,705USD | -4,323,520USD |
| Cash | 4,422,838,000USD | 7,511,079USD | 21,937,749USD | 37,201,786USD | 51,524,295USD | 19,229,232USD | 1,232,030USD | 445,163USD |
| Cash And Short Term Investments | 10,119,224,000USD | 24,013,063USD | 41,302,672USD | 55,196,085USD | 70,725,447USD | 19,229,232USD | 1,232,030USD | 445,163USD |
| Total Current Assets | 10,803,172,000USD | 25,247,629USD | 43,341,325USD | 58,722,737USD | 72,716,400USD | 20,236,922USD | 1,232,818USD | 445,163USD |
| Total Current Liabilities | 4,501,587,000USD | 4,331,175USD | 2,678,186USD | 2,798,297USD | 2,326,167USD | 552,339USD | 489,292USD | 651,629USD |
| Net Debt | -4,344,299,000USD | -7,267,422USD | -21,703,278USD | -37,148,896USD | -51,319,347USD | -19,120,732USD | -1,232,030USD | -445,163USD |
| Short Term Debt | 78,539,000USD | 190,814USD | 172,975USD | 52,890USD | 152,058USD | — | — | — |
| Short Long Term Debt Total | 78,539,000USD | 243,657USD | 234,471USD | 52,890USD | 204,948USD | 108,500USD | — | — |
| Short Term Investments | 5,696,386,000USD | 16,501,984USD | 19,364,923USD | 17,994,299USD | 19,201,152USD | 0USD | — | — |
| Property Plant Equipment Net | 107,470,000USD | 287,425USD | 280,422USD | 95,695USD | 216,188USD | 21,507USD | 8,758USD | 4,668USD |
| Property Plant Equipment Gross | 107,470USD | 287,425USD | 280,422USD | 95,695USD | 216,188USD | 21,507USD | 8,758USD | — |
| Accumulated Other Comprehensive Income | 25,430,000USD | 153,990USD | -107,460USD | -371,386USD | -92,689USD | 0USD | — | — |
| Common Stock Shares Outstanding | 10,898,000shares | 10,762,319shares | 10,842,365shares | 10,850,579shares | 10,904,927shares | 6,220,927shares | 6,265,044shares | 6,217,594shares |
| Non Current Assets Total | 232,639,000USD | 324,163USD | 306,291USD | 113,584USD | 1,234,077USD | 122,712USD | 199,758USD | 4,668USD |
| Non Current Liabilities Total | 0USD | 52,843USD | 61,496USD | 52,890USD | 52,890USD | 108,500USD | 0USD | 0USD |
| Non Currrent Assets Other | 125,169,000USD | 36,738USD | 25,869USD | 17,889USD | 17,889USD | 101,205USD | 191,000USD | 4,668USD |
| Net Working Capital | 6,301,585USD | 20,916,454USD | 40,663,139USD | 55,924,440USD | 70,390,233USD | 19,684,583USD | 743,526USD | -206,466USD |
| Unclassified Equity | 99,652,722,875USD | 97,057,245USD | 96,257,654USD | 95,690,108USD | 96,684,815USD | 32,357,446USD | 7,658,235USD | 4,091,553USD |
| Other Assets | — | 1USD | — | 17,889USD | 1,017,889USD | 101,205USD | 191,000USD | — |
| Net Receivables | — | 97,000USD | 860,000USD | 592,000USD | 181,000USD | — | — | — |
| Accounts Payable | — | 4,140,361USD | 942,211USD | 932,407USD | 2,174,109USD | 432,339USD | 478,292USD | 97,629USD |
| Unclassified Current Liabilities | — | -4,140,361USD | — | — | -1,340,942USD | — | — | — |
| Current Deferred Revenue | — | — | -2,505,211,000USD | -2,745,407USD | -2,174,109USD | — | — | — |
| Inventory | — | — | — | -592,000USD | -181,000USD | — | — | — |
| Net Tangible Assets | — | — | — | 56,038,024USD | 71,571,420USD | 19,698,795USD | 943,040USD | -209,229USD |
| Deferred Long Term Liab | — | — | — | — | — | 101,205USD | 191,000USD | — |
| Long Term Debt | — | — | — | — | — | 108,500USD | — | — |
| Non Current Liabilities Other | — | — | — | — | — | 108,500USD | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow YTD
| Metric | Q2 20262026-06-30 · USD |
|---|---|
| Depreciation | 7,604USD |
| Stock Based Compensation | 548,175USD |
| Change To Liabilities | -243,049USD |
| Change In Working Capital | -645,116USD |
| Operating Cash Flow | -6,713,540USD |
| Net Investments | 4,942,250USD |
| Investing Cash Flow | 4,942,250USD |
| Financing Cash Flow | 3,991,701USD |
| Effect Of Forex Changes On Cash | 16,921USD |
| Change In Cash | 2,237,332USD |
| End Cash Flow | 6,660,170USD |
| Source | DisclosureDeterministicFinal |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -3,329,171USD | -4,074,217USD | -4,177,423USD | -4,331,015USD | -4,536,783USD | -5,875,200USD | -4,505,697USD | -4,959,506USD |
| Depreciation | 3,853USD | 4,103USD | 4,102USD | 4,501USD | 4,574USD | 51,224USD | 4,389USD | 46,266USD |
| Stock Based Compensation | 262,915USD | 198,816USD | 143,685USD | 160,626USD | 147,750USD | 285,499USD | 179,166USD | 134,171USD |
| Other Non Cash Items | 316,039USD | 238,104USD | 114,439USD | -153,274USD | -60,246USD | 253,375USD | -345,763USD | -109,925USD |
| Change In Working Capital | -763,348USD | 841,081USD | -656,783USD | 381,885USD | 69,095USD | 1,313,315USD | -914,348USD | -301,644USD |
| Total Cash From Operating Activities | -3,772,627USD | -2,792,113USD | -4,571,980USD | -3,937,277USD | -4,375,610USD | -3,971,787USD | -5,582,253USD | -5,190,638USD |
| Capital Expenditures | -3USD | -1USD | -560USD | -3USD | -1,159USD | -3,083USD | -3,028USD | -4,267USD |
| Free Cash Flow | -3,772,630USD | -2,792,114USD | -4,572,540USD | -3,937,280USD | -4,376,769USD | -3,974,870USD | -5,585,281USD | -5,194,905USD |
| Investments | 4,250,000USD | -1,703,953USD | 5,928,538USD | 3,593,158USD | 3,239,331USD | 3,447,254USD | 680,345USD | -202,063USD |
| Total Cashflows From Investing Activities | 4,250,000USD | -1,703,954USD | 5,928,538USD | 3,593,158USD | 3,239,331USD | 3,447,254USD | 680,345USD | -202,063USD |
| Change In Cash | 494,958USD | -3,966,648USD | 2,328,078USD | -316,194USD | -1,133,477USD | -591,740USD | -4,873,746USD | -5,381,379USD |
| Begin Period Cash Flow | 4,422,838USD | 8,389,486USD | 6,061,408USD | 6,377,602USD | 7,511,079USD | 8,102,819USD | 12,976,565USD | 18,357,944USD |
| End Period Cash Flow | 4,917,796USD | 4,422,838USD | 8,389,486USD | 6,061,408USD | 6,377,602USD | 7,511,079USD | 8,102,819USD | 12,976,565USD |
| Other Cashflows From Investing Activities | 4,250,000USD | -20,447,502USD | 31,504,575USD | -8,224,344USD | 8,224,344USD | — | 17,408,333USD | -198USD |
| Unclassified Investing Cash Flow | -4,249,997USD | 20,447,502USD | -31,504,015USD | 8,224,347USD | -8,223,185USD | — | -17,405,305USD | — |
| Total Cash From Financing Activities | — | 526,459USD | 971,781USD | 0USD | 66,643,290USD | 0USD | 11,994USD | 0USD |
| Issuance Of Capital Stock | — | 666,208USD | — | — | — | — | — | — |
| Other Cashflows From Financing Activities | — | -139,749USD | 971,781USD | — | 66,643,290USD | — | 11,994USD | -202,063USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -17,119,438USD | -20,781,213USD | -15,961,534USD | -14,259,946USD | -12,363,029USD | -5,908,190USD | -2,428,185USD | -1,726,417USD |
| Depreciation | 17,280USD | 190,493USD | 14,615USD | 10,081USD | 6,761USD | 3,388USD | 1,627USD | -2,544USD |
| Stock Based Compensation | 650,877USD | 732,893USD | 1,067,515USD | 1,187,745USD | 961,545USD | 1,192,241USD | 117,760USD | 185,604USD |
| Other Non Cash Items | 139,023USD | 549,359USD | -5,168USD | 906,491USD | 203,223USD | 1,081,850USD | 117,760USD | -76,324USD |
| Change In Working Capital | 635,278USD | 2,228,160USD | 538,024USD | -611,863USD | 599,957USD | -939,060USD | 180,875USD | 271,840USD |
| Total Cash From Operating Activities | -15,676,980USD | -17,813,201USD | -14,346,548USD | -12,767,492USD | -10,591,543USD | -5,651,621USD | -2,127,923USD | -1,271,517USD |
| Capital Expenditures | -1,715USD | -12,599USD | -18,734USD | -27,844USD | -15,499USD | -16,137USD | -5,717USD | -5,717USD |
| Free Cash Flow | -15,678,695USD | -17,825,800USD | -14,365,282USD | -12,795,336USD | -10,607,042USD | -5,667,758USD | -2,133,640USD | -1,271,517USD |
| Investments | 11,058,788USD | 3,369,368USD | -583,530USD | 207,112USD | -19,515,087USD | -16,137USD | -5,717USD | 5,337USD |
| Total Cashflows From Investing Activities | 11,057,073USD | 3,369,368USD | -930,210USD | 179,268USD | -19,530,586USD | -16,137USD | -5,717USD | 5,337USD |
| Total Cash From Financing Activities | 1,498,240USD | 66,710USD | -499,997USD | -2,182,498USD | 63,416,122USD | 23,664,960USD | 2,920,507USD | 535,000USD |
| Issuance Of Capital Stock | 1,624,547USD | 0USD | — | 0USD | 68,999,994USD | 26,250,000USD | 2,920,507USD | 0USD |
| Change In Cash | -3,088,241USD | -14,426,670USD | -15,805,217USD | -14,781,329USD | 33,295,063USD | 17,997,202USD | 786,867USD | -731,180USD |
| Begin Period Cash Flow | 7,511,079USD | 21,937,749USD | 37,742,966USD | 52,524,295USD | 19,229,232USD | 1,232,030USD | 445,163USD | 1,176,343USD |
| End Period Cash Flow | 4,422,838USD | 7,511,079USD | 21,937,749USD | 37,742,966USD | 52,524,295USD | 19,229,232USD | 1,232,030USD | 445,163USD |
| Other Cashflows From Investing Activities | 11,031,293,944USD | 20,645,048USD | -1USD | 179,268,000USD | -19,530,586,000USD | -5,717,000USD | — | 5,337USD |
| Other Cashflows From Financing Activities | -139,749USD | 66,710USD | -930,210USD | 299,788USD | -5,583,872USD | -2,693,540USD | 2,920,507USD | 535,000USD |
| Unclassified Investing Cash Flow | -11,031,293,944USD | -20,632,449USD | — | -179,268,000USD | 19,530,586,000USD | 5,733,137USD | — | — |
| Change To Account Receivables | — | -175,715USD | -159,255USD | -158,402USD | -71,655USD | — | — | 186,603USD |
| Sale Purchase Of Stock | — | — | -499,997USD | -2,482,286USD | -939,666USD | 26,302,000USD | 2,920,510USD | — |
| Change To Liabilities | — | — | — | 580,359USD | 1,622,084USD | 117,167USD | 372,663USD | 70,237USD |
| Cash And Cash Equivalents Changes | — | — | — | -14,770,722USD | — | 17,997,202USD | — | — |
| Net Borrowings | — | — | — | — | 0USD | 108,500USD | 108,500USD | 108,500USD |
| Unclassified Financing Cash Flow | — | — | — | — | 69,939,660USD | — | -3,029,010USD | — |
| Unclassified Operating Cash Flow | — | — | — | — | — | -1,081,850USD | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
No revenue breakdown is currently published for this company.
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.